CR3 News Magazine 2021 VOL 3: MAY - MEDICAL ISSUE: SURVIVING | Page 42

Zero in on what may make your lung cancer unique , with comprehensive biomarker testing

A lung cancer diagnosis can come out of nowhere . It may feel like you ’ re stuck in a whirlwind of information , but it ’ s important to remember that your voice is your most powerful tool . www . LookCloserAtLungCancer . com
Every lung cancer patient is different
Now is the time to speak up and ask your doctor for a clear view of your complete diagnosis before starting treatment .
START WITH FINDING OUT WHAT MAY MAKE YOUR LUNG CANCER DIAGNOSIS DIFFERENT These differences may open up additional treatment options . Knowing your lung cancer type , stage , and biomarker status from the start may help your doctor choose a treatment option for your specific cancer traits .
BEFORE STARTING TREATMENT , ASK YOUR DOCTOR ABOUT COMPREHENSIVE BIOMARKER TESTING A comprehensive biomarker test can help you and your doctor zero in on the right non – small cell lung cancer ( NSCLC ) treatment for you . This allows your doctor to take a closer look and may reveal important information about what is driving your cancer . Some biomarkers have associated targeted treatments , while others provide information about how well certain treatments may work for you .
COMPREHENSIVE BIOMARKER TESTING HAS CHANGED THE WAY ONCOLOGISTS APPROACH TREATING METASTATIC LUNG CANCER Testing may reveal biomarker-driven therapy options , including targeted treatments . Targeted treatments are commonly prescribed and often can be taken at home orally . Biomarker-driven therapies allow oncologists to center their treatment plans around the unique traits of a patient ’ s metastatic NSCLC .
Biomarker Testing can also be called :